Drug Target Review2026-07-17T12:00:00
A structure-guided peptide vaccine targeting PCSK9 has demonstrated durable antibody responses and reduced LDL cholesterol levels in mouse models of hypercholesterolaemia, offering a potential long-lasting alternative to current lipid-lowering therapies.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-18T11:12:00Z
2026-11-18T07:00:00Z
Contributor Dr Bryan McClellan and Dr William Matsui, Drug Target Review
2026-06-04T07:05:00
Author Graham Craig
2024-01-26T13:22:42
Sponsored by bit.bio
2026-10-07T14:00:00
Sponsored by WuXi AppTec
2023-03-02T13:57:58
Sponsored by Cell Signaling Technology
2024-01-09T09:30:19
Sponsored by Sartorius
Site powered by Webvision Cloud